PNC Financial Services Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
PNC Financial Services Group's VIR Position: Q3 2026 in Review
PNC Financial Services Group increased its Vir Biotechnology (VIR) stake by 1.1% in Q3 2026, buying an estimated $1.14K and bringing the position to 10,966 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #2837.
PNC Financial Services Group first reported a position in VIR in Q1 2020 and has held it in 20 quarters since. The position peaked at $152K in Q1 2024. 266 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- PNC Financial Services Group held 10,966 shares of Vir Biotechnology worth $123K as of Q3 2026.
- PNC Financial Services Group bought 114 Vir Biotechnology shares in Q3 2026, an estimated $1.14K.
- Vir Biotechnology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #2837 holding.
- PNC Financial Services Group first reported a position in Vir Biotechnology in Q1 2020 and has held it in 20 quarters since.
- PNC Financial Services Group's Vir Biotechnology position peaked at $152K in Q1 2024.
- 266 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.